$IKT 3/A SEC Filings

Filed On	Filing
28 Aug 2025	Form 3/A: Cabell Christopher, President & Head of R&D Holds 1,014,846 shares of Common Stock
28 Aug 2025	Form 3/A: Aurentz Vincent, Director Holds 765,895 shares of Common Stock
15 Jul 2025	Form 3/A: Sands Capital Life Sciences Pulse Fund II, L.p., 10% owner and 2 others Holds 10,950,000 shares of Common Stock

Comments